14 Dec 2022
TAVI in 2022 - Lifetime management, durability and clinical relevance to patients
Sponsored by Edwards Lifesciences
Achorperson:
M. Traina
Summary
In this session, a panel of experts address important issues on TAVR, especially regarding younger patients. Join them as they discuss lifetime management, valve durability, and the latest devices' role in extending re-intervention timelines.
Learning Objectives
- To discuss the key considerations of the lifetime management of aortic stenosis patients
- To break down the definition of durability and highlight what matters to patients
- To review the role that latest devices play in extending re-intervention timeline